139 related articles for article (PubMed ID: 25871003)
1. Timing of menopausal hormone therapy and myocardial infarction.
Stuenkel CA
Menopause; 2015 Jun; 22(6):584-6. PubMed ID: 25871003
[No Abstract] [Full Text] [Related]
2. Does menopausal hormone therapy reduce myocardial infarction risk if initiated early after menopause? A population-based case-control study.
Carrasquilla GD; Berglund A; Gigante B; Landgren BM; de Faire U; Hallqvist J; Leander K
Menopause; 2015 Jun; 22(6):598-606. PubMed ID: 25490112
[TBL] [Abstract][Full Text] [Related]
3. [Menopausal hormone replacement therapy and quality of life].
Salmi T
Duodecim; 1996; 112(12):1035-6. PubMed ID: 10593002
[No Abstract] [Full Text] [Related]
4. Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society.
Gambacciani M; Biglia N; Cagnacci A; Caruso S; Cicinelli E; DE Leo V; DI Carlo C; Farris M; Gambera A; Guaschino S; Lanzone A; Paoletti AM; Russo N; Vicariotto F; Villa P; Volpe A;
Minerva Ginecol; 2018 Feb; 70(1):27-34. PubMed ID: 28975776
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy: what we know now.
Roush K
Am J Nurs; 2011 Jun; 111(6):38-47; quiz 48-9. PubMed ID: 21613919
[TBL] [Abstract][Full Text] [Related]
6. Is there a time limit for systemic menopausal hormone therapy?
Lipold LD; Batur P; Kagan R
Cleve Clin J Med; 2016 Aug; 83(8):605-12. PubMed ID: 27505882
[TBL] [Abstract][Full Text] [Related]
7. [Experimental treatment of menopausal disorders by an estrogen-progestogen combination with the estrogen dominant or mixed and then a weak estrogen-progestogen combination].
Dorangeon P
Rev Fr Gynecol Obstet; 1974 Jan; 69(1):49-54. PubMed ID: 17436492
[No Abstract] [Full Text] [Related]
8. Estrogen replacement therapy and asthma.
Ticconi C; Pietropolli A; Piccione E
Pulm Pharmacol Ther; 2013 Dec; 26(6):617-23. PubMed ID: 24035822
[TBL] [Abstract][Full Text] [Related]
9. [Menopause and hormone replacement therapy].
Tóth KS
Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
[TBL] [Abstract][Full Text] [Related]
10. Ultra-low dose - new approaches in menopausal hormone therapy.
Stute P; Becker HG; Bitzer J; Chatsiproios D; Luzuy F; von Wolff M; Wunder D; Birkhäuser M
Climacteric; 2015 Apr; 18(2):182-6. PubMed ID: 25335192
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for hormone treatment of women in the menopausal transition and beyond.
Naftolin F; Schneider HP; Sturdee DW;
Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104
[No Abstract] [Full Text] [Related]
12. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms.
Carroll N
J Womens Health (Larchmt); 2010 Jan; 19(1):47-55. PubMed ID: 20088658
[TBL] [Abstract][Full Text] [Related]
13. Global consensus statement on menopausal hormone therapy.
de Villiers TJ; Gass ML; Haines CJ; Hall JE; Lobo RA; Pierroz DD; Rees M
Climacteric; 2013 Apr; 16(2):203-4. PubMed ID: 23488524
[TBL] [Abstract][Full Text] [Related]
14. [Coronary artery disease and menopausal hormone therapy].
Mizia-Stec K; Zahorska-Markiewicz B; Gasior Z; Holecki M
Pol Arch Med Wewn; 2004 Oct; 112(4):1255-63. PubMed ID: 15773440
[No Abstract] [Full Text] [Related]
15. Hormone therapy and coronary heart disease in young women.
Weiner MG; Barnhart K; Xie D; Tannen RL
Menopause; 2008; 15(1):86-93. PubMed ID: 17502840
[TBL] [Abstract][Full Text] [Related]
16. Addendum: Transdermal estrogen (Med Lett Drugs Ther 2012;54:41).
Med Lett Drugs Ther; 2012 Jul; 54(1394):56. PubMed ID: 22826825
[No Abstract] [Full Text] [Related]
17. Exogenous and endogenous estrogens: an appreciation of biological complexity.
Kronenberg F; Hughes C
Menopause; 1999; 6(1):4-6. PubMed ID: 10100173
[No Abstract] [Full Text] [Related]
18. Menopausal hormone replacement therapy in dermatology.
Danby FW
JAMA Dermatol; 2014 Dec; 150(12):1261-2. PubMed ID: 25250584
[No Abstract] [Full Text] [Related]
19. [Indications and controindications of hormone replacement therapy in menopause].
Fichera M; Rinaldi N; Tarascio M; Taschetta S; Caldaci LM; Catavorello A; La Rosa B; Panella MM
Minerva Ginecol; 2013 Jun; 65(3):331-44. PubMed ID: 23689177
[TBL] [Abstract][Full Text] [Related]
20. Transdermal hormone replacement therapy with nanostructured medicines.
Abdi F; Darooneh T; Ghorbani M; Banihashemi F; Roozbeh N
Ginekol Pol; 2017; 88(2):103-108. PubMed ID: 28326520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
